[
  {
    "id": "ab7ac10b-58cc-4372-a567-0e02b2c3d479",
    "name": "BE-X5",
    "identifiers": [
      {
        "type": "nct",
        "identifier": "NCT75521706"
      }
    ],
    "status": "Planning",
    "title": "Effect of combination of device Megabond with varying doeses of Amoxocillin Treatment of Patients With Advanced Malignancies",
    "phase": "III",
    "interventions": [
      {
        "type": "device",
        "name": "Megabond 5000"
      },
      {
        "type": "drug",
        "name": "Amoxocillin"
      }
    ],
    "therapeuticArea": "Oncology",
    "currentProtocol": "v1",
    "protocolAmendments": [
      {
        "version": "v1",
        "date": "04-MAR-2024",
        "description": "initial protocol"
      }
    ]
  },
  {
    "id": "c134550f-359a-4254-829b-7b141340b403",
    "name": "CLIVE",
    "title": "",
    "status": "Planning",
    "phase": "I",
    "therapeuticArea": "Oncology",
    "currentProtocol": ""
  }
]